Legal & General Group PLC Pacira Bio Sciences, Inc. Transaction History
Legal & General Group PLC
- $440 Billion
- Q2 2024
A detailed history of Legal & General Group PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 129,297 shares of PCRX stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,297
Previous 128,440
0.67%
Holding current value
$1.98 Million
Previous $3.75 Million
1.44%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding PCRX
# of Institutions
303Shares Held
51.6MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$123 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$77.8 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$33.1 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$31.6 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$29.1 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $701M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...